(S)-1-((11bS,12S,14aR)-13-methoxy-2,3,5,6,11b,12-hexahydro-1H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]cyclopenta[b]pyrrolo[1,2-a]azepin-12-yl)4-methyl 2-methylsuccinate

ID: ALA5268511

Chembl Id: CHEMBL5268511

Max Phase: Preclinical

Molecular Formula: C24H29NO7

Molecular Weight: 443.50

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)C[C@H](C)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4

Standard InChI:  InChI=1S/C24H29NO7/c1-14(9-20(26)29-3)23(27)32-22-19(28-2)12-24-6-4-7-25(24)8-5-15-10-17-18(31-13-30-17)11-16(15)21(22)24/h10-12,14,21-22H,4-9,13H2,1-3H3/t14-,21+,22+,24-/m0/s1

Standard InChI Key:  IKUUNWYBSKSARU-ORMZAIONSA-N

Alternative Forms

  1. Parent:

    ALA5268511

    ---

Associated Targets(Human)

K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-937 (7138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 443.50Molecular Weight (Monoisotopic): 443.1944AlogP: 2.54#Rotatable Bonds: 5
Polar Surface Area: 83.53Molecular Species: BASEHBA: 8HBD: 0
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.42CX LogP: 2.04CX LogD: 0.03
Aromatic Rings: 1Heavy Atoms: 32QED Weighted: 0.64Np Likeness Score: 1.98

References

1. Yang Y, Yu Q, Hu L, Dai B, Qi R, Chang Y, Zhang Q, Zhang Z, Li Y, Zhang X..  (2022)  Enantioselective semisynthesis of novel cephalotaxine esters with potent antineoplastic activities against leukemia.,  244  [PMID:36242991] [10.1016/j.ejmech.2022.114731]

Source